時富投資(01049.HK):預計2020財年淨利不少於3000萬港元
格隆匯 2 月 5日丨時富投資(01049.HK)發佈公吿,集團預期2020財政年度將錄得溢利淨額不少於3000萬港元,而2019年同期錄得虧損淨額約1.004億港元。
公吿稱,預期扭轉2020財政年度財務業績主要來自包括但不限於在新冠肺炎疫情大流行之時,成功地推動實惠網上銷售,並提高整個供應鏈的靈活性,擴大產品種類,如消毒用品、食品和其他“宅經濟”必需品,以迎合顧客新的“宅經濟”生活模式;實惠集團的公司仍能保持與去年相約的收益水平;實惠家居用品的毛利潤有所改善;整體營運成本合理化,歸因於集團自2018年12月以來實施的成本優化計劃,包括領取香港特別行政區政府根據“保就業”計劃提供的補貼。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.